Art

J-GLOBAL ID：200902145595742854   Reference number：01A0600159

Peritoneal Clearance and Optimum Dosage Regimen of Levofloxacin in Patients under Continuous Ambulatory Peritoneal Dialysis.

持続腹膜透析通院患者におけるレボフロキサシンの腹膜クリアランスおよび最適用量管理について

Author (7)： KANAMORI M (Meiji Pharmaceutical Univ., Tokyo, JPN) ,  MIHARA K (Meiji Pharmaceutical Univ., Tokyo, JPN) ,  HANADA K (Meiji Pharmaceutical Univ., Tokyo, JPN) ,  YASUDA T (St. Marianna Univ. School of Medicine) ,  FUJINO T (St. Marianna Univ. School of Medicine) ,  SATOH T (St. Marianna Univ. School of Medicine) ,  OGATA H (Meiji Pharmaceutical Univ., Tokyo, JPN)
Material： 臨床薬理  (Japanese Journal of Clinical Pharmacology and Therapeutics)
Volume： 32  Issue： 3  Page： 91-99  Publication year： May. 31, 2001 
JST Material Number： F0384B  ISSN： 0388-1601  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： *CAPD

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=01A0600159&from=J-GLOBAL&jstjournalNo=F0384B") }}

JST classification (2)： Surgical treatment for urogenital diseases  (GM05030G) ,  Clinical application of antibacterial drugs  (GW17030D)

Substance index (1)： Levofloxacin

Reference (14)：

• KUBO, K. Anoutline of continuous ambulatory peritoneal dialysis (CAPD). Nihonrinsyou. 1991, 49, 472-477
• PIRAINO, B. A five-year study of the microbiologic resultof exit site infection and peritonitis in continuous ambulatory peritoneal dialysis. Am. J. Kidney. Dis. 1987, 10, 281-286
• IMAMURA, M. Inhibition of DNA gyrase by optically active ofloxacin. Antimicrob. Agents. Chemother. 1987, 31, 325-327
• SAITO, A. Pharmacokinetics of levofloxacin in patients with impaired renal function. Chemotheropy. 1992, 40, 188-194
• FISH, D. N. The clinical pharmacokinetics of levofloxacin. Clin. Pharmacokinet. 1997, 32, 101-119

Terms in the title (6)： 腹膜透析 ,  通院患者 ,  レボフロキサシン ,  腹膜 ,  クリアランス ,  最適用量